Education and Training
- Fellow in Cardiology, Medicine, Duke University, 2002 - 2006
- Medical Resident, Medicine, Duke University, 1999 - 2002
- M.D., University of Massachusetts at Amherst, 1999
Frost, A, Janmohamed, M, Fritz, JS, McConnell, JW, Poch, D, Fortin, TA, Miller, CE, Chin, KM, Fisher, M, Eggert, M, McEvoy, C, Benza, RL, Farber, HW, Kim, NH, Pfister, T, Shiraga, Y, and McLaughlin, V. "Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study." The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation 38, no. 1 (January 2019): 43-50.
Parikh, KS, Rajagopal, S, Fortin, T, Tapson, VF, and Poms, AD. "Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension." Journal of cardiovascular pharmacology 67, no. 4 (April 2016): 322-325.
Rajagopal, S, Forsha, DE, Risum, N, Hornik, CP, Poms, AD, Fortin, TA, Tapson, VF, Velazquez, EJ, Kisslo, J, and Samad, Z. "Comprehensive assessment of right ventricular function in patients with pulmonary hypertension with global longitudinal peak systolic strain derived from multiple right ventricular views." Journal of the American Society of Echocardiography 27, no. 6 (January 1, 2014): 657-665.e3.
Meine, TJ, Patel, MR, Heitner, J, Fortin, TA, Pagnanelli, RA, Gehrig, TR, Kim, R, and Borges-Neto, S. "Cardiac imaging impaired by a silicone breast implant." Clin Nucl Med 30, no. 4 (April 2005): 262-264.
McLaughlin, VV, Presberg, KW, Doyle, RL, Abman, SH, McCrory, DC, Fortin, T, Ahearn, G, and American College of Chest Physicians, . "Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines." Chest 126, no. 1 Suppl (July 2004): 78S-92S. (Review)
McGoon, M, Gutterman, D, Steen, V, Barst, R, McCrory, DC, Fortin, TA, Loyd, JE, and American College of Chest Physicians, . "Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines." Chest 126, no. 1 Suppl (July 2004): 14S-34S.
Ramanathan, KB, Folland, ED, Fortin, T, Hartigan, P, Boucher, CA, and Parisi, AF. "Accuracy and limitations of planar thallium scintigraphy for identifying the involved coronary artery in patients with single-vessel disease: Findings in the ACME trial." Cardiovascular Reviews and Reports 22, no. 2 (January 1, 2001): 115-120.
Gibson, CM, Cannon, CP, Daley, WL, Dodge, JT, Alexander, B, Marble, SJ, McCabe, CH, Raymond, L, Fortin, T, Poole, WK, and Braunwald, E. "TIMI frame count: a quantitative method of assessing coronary artery flow." Circulation 93, no. 5 (March 1996): 879-888.
Strauss, WE, Fortin, T, Hartigan, P, Folland, ED, and Parisi, AF. "A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy: Outcomes of a randomized clinical trial." Circulation 92, no. 7 (1995): 1710-1719.
Folland, ED, Vogel, RA, Hartigan, P, Bates, ER, Beauman, GJ, Fortin, T, Boucher, C, and Parisi, AF. "Relation between coronary artery stenosis assessed by visual, caliper, and computer methods and exercise capacity in patients with single-vessel coronary artery disease." Circulation 89, no. 5 (1994): 2005-2014.